REGISTERED NUMBER: 04560205 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2025

FOR

ANSER MEDICAL GROUP LTD.

PREVIOUSLY KNOWN AS

GOOSE MARKETING LIMITED

Page

Balance Sheet

1

FIXED ASSETS

30,137

25,157

CURRENT ASSETS

211,694

199,541

CREDITORS

Amounts falling due within one year

(69,622

)

(95,442

)

NET CURRENT ASSETS

142,072

104,099

TOTAL ASSETS LESS CURRENT LIABILITIES

172,209

129,256

ACCRUALS AND DEFERRED INCOME

(3,150

)

(3,000

)

NET ASSETS

169,059

126,256

CAPITAL AND RESERVES

169,059

126,256

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Anser Medical Group Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

04560205

Registered office:

11 Whiteshot Way

Saffron Walden

Essex

CB10 2AN

The presentation currency of the financial statements is the Pound Sterling (£).

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2024 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 15 July 2026 and were signed by:

E F Meanwell - Director